Month: September 2020

PURCHASE, NY, Sept. 08, 2020 (GLOBE NEWSWIRE) — Teladoc Health, Inc. (NYSE: TDOC), the global leader in virtual care, announced today that executives from the Company, together with executives of Livongo, will participate in the following upcoming investor conferences:Wells Fargo Securities Healthcare Conference on Thursday, September 10 at 8:00 a.m. EasternMorgan Stanley 18th Annual Global Healthcare Conference on Wednesday, September 16 at 9:30 a.m. Eastern TimeA live audio webcast and replay of the presentation will be available at http://ir.teladochealth.com/news-and-events/events-and-presentations/.About Teladoc HealthTeladoc Health is transforming how people access and experience healthcare. Recognized as the world leader in virtual care, Teladoc Health directly delivers millions of medical visits across 175 countries each...

– PK and PD profiles of macimorelin for pediatric use were within the expected range and comparable to results observed in adults –– Data from this study support the choice of 1.0 mg/kg dose of macimorelin for validity testing in a Phase 3 trial, expected to commence in Q1 2021 –CHARLESTON, S.C., Sept. 08, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced the presentation of results from its first pediatric study of macimorelin as a growth hormone stimulation test for the evaluation of childhood-onset growth hormone deficiency (“CGHD”) at the 22nd European Congress of Endocrinology (e-ECE 2020), being held September 5-9, 2020.The data were presented...

MELBOURNE, Australia, Sept. 08, 2020 (GLOBE NEWSWIRE) — Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive efficacy data from a study of its induced pluripotent stem cell (iPSC)-derived Cymerus™ mesenchymal stem cells (MSCs) in a preclinical rodent model of idiopathic pulmonary fibrosis (IPF).     Key highlights:Efficacy demonstrated in preclinical rodent model of IPF, a disease which causes severe lung damage and leads to respiratory failureExisting treatments for IPF have limited efficacyTreatment with Cynata’s Cymerus MSCs led to statistically significant improvements in multiple harmful effects of IPF, including interstitial fibrosis, dynamic lung compliance and airway resistanceDr. Kilian Kelly, Cynata’s...

Company to focus expanded D&I efforts across key areas of colleagues, culture and communities with commitments to: Double U.S. Black representation in management by 2024Spend $1 billion annually with minority- and women-owned businesses by 2024Appoint Global Chief Diversity & Inclusion Officer CHICAGO, Sept. 08, 2020 (GLOBE NEWSWIRE) — Mondelēz International, Inc. (NASDAQ:MDLZ) announced today a multi-year commitment focused on elevating its existing diversity and inclusion initiatives to make meaningful impacts in the area of racial equity economic empowerment around the world. The plan is designed to accelerate the company’s existing D&I efforts following extensive consultations between company leaders, colleagues and experts through listening forums and educational sessions focused on diversity, inclusion and belonging.“Mondelēz...

Automated Coding Analysis for Inpatient and Outpatient CareAtlanta, GA, Sept. 08, 2020 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), provider of the eValuator™ Revenue Integrity Program to help healthcare providers proactively address revenue leakage and compliance exposure, today announced it has signed a contract with a large health system in the Mid-Atlantic region. The health system will use eValuator’s cloud-based automated pre- and post-bill coding analysis technology to help improve revenue integrity for their inpatient and outpatient services.Streamline Health is leading an industry movement to enable every hospital in the country to use pre-bill technology to improve financial performance. With eValuator, providers are identifying and addressing coding issues before they contribute to revenue leakage,...

Sjá meðfylgjandi tilkynningu um flöggun frá Stefni hf. þar sem farið er undir 5% eignarhlut í Regin hf.ViðhengiReginn hf. – Flöggun – Stefnir hf. – 08092020

The Preliminary Economic Assessment (“PEA”) was prepared in accordance with the requirements of the National Instrument 43-101,Standards of Disclosure for Mineral Projects (“NI43-101”) (refer release on 4 August 2020) and is based on a Mineral Resource Estimate (“MRE”) completed by NCL, which comprised 70 million tonnes, with an average grade of 0.60% total copper within the Measured & Indicated Categories of mineral resources (approximately 420Kt of contained copper),and 40 million tonnes with an average grade of 0.52% total copper within the Inferred Category of mineral resources(approximately 224kt of contained copper) (refer release on 2 December 2019). The PEA is considered preliminary in nature and includes Inferred Mineral Resources that are considered too speculative, geologically, to have the economic considerations applied...

Key Highlights:Crucial® Ballistix® MAX 5100 memory is the fastest available on the market1New offering expands the award-winning Crucial Ballistix gaming memory product portfolioTuned Micron® die sets the standard for extreme-performance memoryThis high-performance memory was used to set overclocking world record on Aug. 18, 2020Limited edition quantities are available globally while supplies lastBOISE, Idaho, Sept. 08, 2020 (GLOBE NEWSWIRE) — Crucial, Micron’s global consumer brand of computer memory and storage, today announced its limited edition Crucial Ballistix MAX 5100 gaming DRAM. Expanding on the award-winning legacy of the Crucial Ballistix product portfolio, this latest offering provides consumers with an optimal gaming memory option, boasting the highest speeds available to date for purchase.Crucial Ballistix is the only...